Navigation Links
Solving the Z ring's mysteries may lead to new antibiotics

A team led by Johns Hopkins researchers has solved important puzzles concerning how certain proteins guide the reproduction of bacteria, discoveries that could lead to a new type of antibiotics.

In a recent study published in the journal Current Biology, the scientists reported how a belt-like structure called a Z ring, which pinches a rod-shaped bacterium to produce two offspring, can be disabled by a protein called MinC. By exploiting this vulnerability, the researchers said, pharmaceutical companies may find a way to fight infections that no longer respond to older medications.

The potential medical applications of our discovery are significant, said Alex Dajkovic, lead author of the paper. Because the molecules involved in cell division are very similar in almost all bacteria, the process we uncovered provides a new target for the people who make antibiotics. This is extremely important because antibiotic resistance is on the rise, and many preventable deaths, especially in the developing world, are caused by bacterial infections.

Dajkovic helped make the discoveries as a postdoctoral fellow in the lab of Denis Wirtz, a professor of chemical and biomolecular engineering in Johns Hopkins Whiting School of Engineering. Dajkovic is now a researcher at Institut Curie in Paris.

Wirtz, who also is associate director of the Johns Hopkins Institute for NanoBioTechnology, noted that most antibiotics target the ability of bacteria to build their cell walls or their ability to make proteins or DNA. With this paper, Alex and the rest of the team identified new molecular targets that could disrupt bacterial cell division. If the bacteria cant reproduce, the infection will die.

The researchers focused on the rod-shaped bacterium E. coli, commonly found in the human digestive tract, which serves as a model organism for study of basic bacterial processes. When these single-celled microbes want to multiply, a structure called the Z ring forms, then begins to tighten like a rubber band around each bacteriums midsection. The Z ring helps to pinch the rod-shaped body into two microbial sausages that finally split apart to form two cells.

For about 20 years, researchers have known about the Z ring but have not understood precisely how it operated and why it always formed in the middle of rod-shaped cells. The main components of Z rings are filaments of a protein molecule called FtsZ

In the new journal article, the Johns Hopkins-led researchers were able to report for the first time that the changing of FtsZ threads from a liquid-like form to a more solid structure inside the cell is important for the formation of the Z ring. The team found that FtsZ threads weave themselves into a framework or scaffold that can hold all of the other molecules involved in the cell division process. The FtsZ filments are able to weave this tapestry, the researchers learned, because they tend to attract one another and interact along the length of each thread.

The team also discovered that MinC, another protein inside the bacterial cell, disrupts this process by liquefying the structure that is used to form a Z ring. MinC blocks the attraction between FtsZ filaments along their lengths, and it also makes the filaments more fragile, said Dajkovic. This has the effect of shearing the weavings in the tapestry of the Z ring, which causes the whole structure to fall apart.

MinC is most prevalent on the outer ends of the rod-shaped bacterial cell, the researchers said, and this explains why the Z ring always forms and splits the cell in the middle, where it is less likely to encounter its protein foe. The team members said this discovery also presents a promising opportunity: a new drug that mimics the effects of MinC could play havoc with the bacterial reproductive process and thereby put an end to an infection.

The findings resulted from a collaboration involving Dajkovic, whose background is in cell biology and biochemistry; Wirtz, whose expertise is in biophysics and engineering; and Sean X. Sun, a Johns Hopkins assistant professor of mechanical engineering who provided computational modeling of the cell division process. Wirtz and Sun were co-authors of the Current Biology paper, along with Ganhui Lan, a doctoral student in Suns lab, and Joe Lutkenhaus, a University Distinguished Professor in the Department of Microbiology, Molecular Genetics and Immunology at the University of Kansas Medical Center. Lutkenhaus was Dajkovics faculty advisor as a doctoral student.


Contact: Phil Sneiderman
Johns Hopkins University

Related biology technology :

1. The American Fertility Association Brings Fertility Education to San Francisco or Parent Hopefuls - Straight and Gay
2. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
3. Purdue creating wireless sensors to monitor bearings in jet engines
4. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
5. Doping technique brings nanomechanical devices into the semiconductor world
6. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ATS Medical Expands Open Pivot Heart Valve Offerings
9. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
10. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
Post Your Comments:
Related Image:
Solving the Z ring's mysteries may lead to new antibiotics
(Date:11/30/2015)... Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that ... its Board of Directors to replace Dr. Peter Johann ... experience as co-founder of Resverlogix, with expertise in the fields ... --> Dr. Wong remarked, "I am very excited ... standing expertise in epigenetics and the advanced stage of the ...
(Date:11/30/2015)... , November 30, 2015 TapImmune, ... the development of innovative peptide and gene-based immunotherapeutics and ... today announced it will be presenting at the 8 ... 1, 2015 at 2.30 PM PT. Dr. John ... Advisor will be giving the presentation and will join ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... to adding an additional independent director, and the Company ... investigation of allegations in a recent anonymous internet report ... on both initiatives. Linda Powers stated, ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... includes over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, and ... covers a wide range of applications such as, but not limited to, biotechnology, ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/27/2015)... NEW YORK , Oct. 27, 2015 ... the major issues of concern for various industry verticals ... This is due to the growing demand for secure ... practices in various ,sectors, such as hacking of bank ... concerns for electronic equipment such as PC,s, laptops, and ...
Breaking Biology News(10 mins):